Use of Etonogestrel implant beyond approved duration - A case report

Bibliographic Details
Main Author: Carvalho,Carolina Castro
Publication Date: 2022
Other Authors: Reis,Inês Silveira, Machado,Ana Isabel
Format: Report
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000200163
Summary: Abstract The contraceptive implant is the most effective method of reversible contraception. Observational and trial data indicate that this method remains effective beyond the initially approved duration of use. We report a case of etonogestrel serum levels above the supposed threshold value for ovulation suppression nine years after implant insertion.
id RCAP_2e4330494080da816a2c62396610b1be
oai_identifier_str oai:scielo:S1646-58302022000200163
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Use of Etonogestrel implant beyond approved duration - A case reportEtonogestrel implantContraceptive effectivenessNexplanon®Implanon NXT®Family planningAbstract The contraceptive implant is the most effective method of reversible contraception. Observational and trial data indicate that this method remains effective beyond the initially approved duration of use. We report a case of etonogestrel serum levels above the supposed threshold value for ovulation suppression nine years after implant insertion.Euromédice, Edições Médicas Lda.2022-06-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000200163Acta Obstétrica e Ginecológica Portuguesa v.16 n.2 2022reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000200163Carvalho,Carolina CastroReis,Inês SilveiraMachado,Ana Isabelinfo:eu-repo/semantics/openAccess2024-02-06T17:21:56Zoai:scielo:S1646-58302022000200163Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T13:09:16.887792Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Use of Etonogestrel implant beyond approved duration - A case report
title Use of Etonogestrel implant beyond approved duration - A case report
spellingShingle Use of Etonogestrel implant beyond approved duration - A case report
Carvalho,Carolina Castro
Etonogestrel implant
Contraceptive effectiveness
Nexplanon®
Implanon NXT®
Family planning
title_short Use of Etonogestrel implant beyond approved duration - A case report
title_full Use of Etonogestrel implant beyond approved duration - A case report
title_fullStr Use of Etonogestrel implant beyond approved duration - A case report
title_full_unstemmed Use of Etonogestrel implant beyond approved duration - A case report
title_sort Use of Etonogestrel implant beyond approved duration - A case report
author Carvalho,Carolina Castro
author_facet Carvalho,Carolina Castro
Reis,Inês Silveira
Machado,Ana Isabel
author_role author
author2 Reis,Inês Silveira
Machado,Ana Isabel
author2_role author
author
dc.contributor.author.fl_str_mv Carvalho,Carolina Castro
Reis,Inês Silveira
Machado,Ana Isabel
dc.subject.por.fl_str_mv Etonogestrel implant
Contraceptive effectiveness
Nexplanon®
Implanon NXT®
Family planning
topic Etonogestrel implant
Contraceptive effectiveness
Nexplanon®
Implanon NXT®
Family planning
description Abstract The contraceptive implant is the most effective method of reversible contraception. Observational and trial data indicate that this method remains effective beyond the initially approved duration of use. We report a case of etonogestrel serum levels above the supposed threshold value for ovulation suppression nine years after implant insertion.
publishDate 2022
dc.date.none.fl_str_mv 2022-06-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000200163
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000200163
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S1646-58302022000200163
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Euromédice, Edições Médicas Lda.
publisher.none.fl_str_mv Euromédice, Edições Médicas Lda.
dc.source.none.fl_str_mv Acta Obstétrica e Ginecológica Portuguesa v.16 n.2 2022
reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833593488208297984

Similar Items